A stool sample records the present. A comparison of microbial genomes can ask a much older question: how did their ancestors travel? The interesting part is the bridge between those two kinds of evidence.
- Count people, specimens and species separately.
- A reconstructed history depends on an explicit model of genetic change.
- Ancient association is a starting point for functional research, not a health ranking.
- Publication
- Nature · 7 October 2026
- Research stage
- Population-genetic inference
- Question here
- What can a shared species tell us?
Original publication: 7 Oct 2026 · The date above refers to this brief.
Shared species within the recovered Tsimane catalogue
species
The new finding
Carter and colleagues compared contemporary Tsimane and Hadza microbiomes. Shared species, genetic divergence and gene-flow patterns support ancient co-migration with humans. This is an inference from present-day genomes, rather than direct sequencing of prehistoric specimens.
Source 1 ↗Start with the denominator
The chart uses the Tsimane species catalogue as its denominator. Its two bars overlap: the shared set belongs inside the recovered set. Neither bar represents an individual person’s microbiome.
Our calculation divides the shared count by the catalogue total and rounds to one decimal place. Before reusing that percentage, write down exactly what belongs in the denominator. A percentage of recovered species is different from the percentage of people carrying one species. Combining those statements would change the question without changing the headline.
Three explanations to keep apart
Finding the same species in distant places leaves several possible histories open. It could have stayed associated with separated populations, moved between them recently, or arrived through another route. Species identity alone cannot choose among those explanations.
For a reader, the useful next question is what additional genetic pattern makes one history more plausible. Look for a comparison of relatedness within and between populations, then ask which assumptions convert that pattern into elapsed time. A historical reconstruction should show its dependence on mutation rates and gene exchange rather than presenting an exact date as an observed event.
Why the sampling units matter
A person can provide repeated specimens. A specimen can contribute fragments assigned to many organisms. A reconstructed genome and a species catalogue therefore occupy different levels of the analysis.
Our proposed reporting improvement is a short flow diagram beside every microbiome headline: people → specimens → reconstructed genomes → species eligible for the particular analysis. Preserve exclusions at each step. That makes it easier to see whether a comparison describes broad recovery, a sufficiently sampled subset or an individual outcome.
From evolutionary history to a useful next experiment
Our suggested follow-up would choose a defined microbial function, test it in a controlled system, and specify what would count as benefit or harm before drawing a health conclusion. Presence, persistence and biological effect are separate questions.
Sampling should also be designed with participating communities, including decisions about data use and the value returned to them. Historical interest does not make a contemporary population a frozen representation of the past. This is our interpretation of a responsible next research step, not a claim that restoring a particular organism has been shown to improve health.
Read this alongside our biological-map guide
A species inventory asks what is present. A mechanism study asks how a specified change produces an effect. Our guide on moving from biological maps to mechanisms helps connect these questions while preserving their different evidence requirements.
The promising opportunity is to make the historical hypothesis testable at the level of function. A useful future report would link one evolutionary pattern to one measured process and show which alternative explanations remain.
A denominator you can inspect
Primary count locations checked; the only calculation uses printed species counts. No genomic inference reproduced.
01Is the past directly observed?
- What was observed
- Present-day genomes support a reconstruction.
- Where the conclusion stops
- Timing is inferred.
Source 1 · Abstract; Discussion
02Does a shared species establish benefit?
- What was observed
- Species overlap is the measured pattern.
- Where the conclusion stops
- Benefit needs an intervention test.
Source 1 · Abstract; Discussion
Numbers you can inspect
| Measure | Value & unit | Origin & method |
|---|---|---|
| Tsimane cohort | 85 adults | Reported People, not specimens. Source 1 · Sequencing and genome recovery |
| Tsimane specimens | 133 faecal samples | Reported Repeated sampling is possible. Source 1 · Sequencing and genome recovery |
| Tsimane catalogue | 1408 species | Reported Recovered bacterial and archaeal species. Source 1 · Sequencing and genome recovery |
| Shared catalogue | 1231 species | Reported Recovered in both cohorts. Source 1 · Figure 1; shared-species analysis |
| Genetic-comparison subset | 636 species | Reported At least four genomes per population. Source 1 · Figure 1 caption |
| Shared fraction | 87.4 percent | Calculated 1,231 / 1,408 × 100; round to one decimal. Source 1 · Figure 1; sequencing and genome recovery |
Compare the actual experiments
These studies answer different questions. Read the unit and endpoint before comparing results.
| Study | Unit & setting | Readout | Interpretation boundary |
|---|---|---|---|
| Carter et al. 2026 Source 1 · Abstract; Discussion | Microbial populations | Genetic history | No demonstrated health effect. |
The export includes claims, available numbers, methods and source locations. It contains our reading notes and published summaries; it is not raw participant data or an independent reanalysis.
Evidence update · 7 Oct 2026
First publication. Reported numbers retain their units and source locations. Calculations are labelled. Interpretation and proposed experiments are ours; no participant data or experimental records were reanalysed. AI source check; no human editorial or clinical review.
Four questions that need different evidence
| Question | Evidence to look for | What remains open |
|---|---|---|
| What is present? | Species recovery and coverage | Function and individual health |
| How did it arrive? | Genetic relatedness and a historical model | Alternative routes and clock assumptions |
| What does it do? | A defined functional assay | Effects in other biological contexts |
| Would changing it help? | A prospective intervention and relevant outcomes | Benefits, harms and durability |
Our reading framework; the rows are questions, not four results from this paper.
Your questions, answered
Does shared mean genetically identical?
No. A species category can include different strains. Ask what level of relatedness the analysis actually measures.
Are these prehistoric stool samples?
No; the historical reconstruction uses contemporary microbiomes.
Can I use this to choose a probiotic?
This article supplies no product comparison or intervention result. A functional hypothesis would need its own test.
What can I check in the download?
The counts, denominator calculation, source locations and boundaries. It is a bibliographic evidence sheet, not participant data.
Limits of this interpretation
- Historical timing depends on evolutionary-model assumptions.
- The populations sampled do not represent every setting.
- Species detection does not establish a health benefit.
- No microbial restoration intervention is evaluated here.
Sources & transparency
- Carter, Liu, Olm et al. (2026): Prehistoric global migration of vanishing gut microbes with humans
Publisher HTML abstract, sequencing and genome recovery, shared-species analysis, Figure 1, gene-flow interpretation, Discussion and ethics statement checked. No supplementary derivations, raw reads or source-data reanalysis. Original commentary and count chart; no publisher text or figures reproduced. · Accessed 7 Oct 2026
DOI: 10.1038/s41586-026-11106-1
Prepared and source-checked with AI. Press-news Team is the collective publication byline, not a medical reviewer. No human editorial or clinical review has taken place. This educational article explains research methods and basic research; it does not provide individual diagnosis or treatment recommendations. We did not conduct these experiments or reanalyse participant data. Findings, interpretation and proposed follow-up tests are distinguished. Source access is recorded below. Photographs are illustrative.
Source check: AI source check — named primary passages, measurement units and interpretation boundaries
Clinical review: Not applicable to this educational guide
Suggest a correction